Travel Injections Ltd Filleted Accounts Cover |
Company No. 10726704 | |||||||||
Travel Injections Ltd Directors Report Registrar |
The Directors present their report and the accounts for the year ended 30 April 2025. | |||||||||
Principal activities | |||||||||
Directors | |||||||||
The Directors who served at any time during the year were as follows: | |||||||||
J.N. Issac | |||||||||
P.S. Sagoo | |||||||||
P.S. Saundh | |||||||||
S.S. Sihra | |||||||||
Signed on behalf of the board | |||||||||
S.S. Sihra | |||||||||
Director | |||||||||
04 January 2026 | |||||||||
Travel Injections Ltd Balance Sheet Registrar |
at | ||||||||||
Company No. | Notes | 2025 | 2024 | |||||||
£ | £ | |||||||||
Fixed assets | ||||||||||
Tangible assets | 5 | |||||||||
Creditors: Amount falling due within one year | 6 | ( | ( | |||||||
Net current liabilities | ( | ( | ||||||||
Total assets less current liabilities | ( | ( | ||||||||
Net liabilities | ( | ( | ||||||||
Capital and reserves | ||||||||||
Called up share capital | ||||||||||
Profit and loss account | 8 | ( | ( | |||||||
Total equity | ( | ( | ||||||||
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on 04 January 2026 and signed on its behalf by: | ||||||||||
S.S. Sihra | ||||||||||
Director | ||||||||||
04 January 2026 | ||||||||||
Travel Injections Ltd Notes to the Accounts Registrar |
for the year ended 30 April 2025 | ||||||||||||||
1 | General information | |||||||||||||
Travel Injections Ltd is a private company limited by shares and incorporated in England and Wales. | ||||||||||||||
Its registered number is: 10726704 | ||||||||||||||
Its registered office is: | ||||||||||||||
2 | Accounting policies | |||||||||||||
Revenue recognition | ||||||||||||||
Tangible fixed assets and depreciation | ||||||||||||||
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. | ||||||||||||||
Plant and machinery | ||||||||||||||
Leased assets | ||||||||||||||
Trade and other creditors | ||||||||||||||
3 | Employees | |||||||||||||
2025 | 2024 | |||||||||||||
Number | Number | |||||||||||||
The average monthly number of employees (including directors) during the year was: | ||||||||||||||
4 | Taxation | |||||||||||||
(a) Tax on profit on ordinary activities | 2025 | |||||||||||||
The tax charge is made up as follows: | £ | |||||||||||||
UK corporation tax | ||||||||||||||
(b) Factors affecting the total tax charge for the period | ||||||||||||||
Profit on ordinary activities before tax | ( | |||||||||||||
Standard rate of corporation tax in the United Kingdom | ||||||||||||||
Profit on ordinary activities multiplied by standard rate of corporation tax in the United Kingdom | ( | |||||||||||||
Expenses not deductible for tax purposes | ||||||||||||||
5 | Tangible fixed assets | |||||||||||||
Plant and machinery | Total | |||||||||||||
£ | £ | |||||||||||||
Cost or revaluation | ||||||||||||||
At 1 May 2024 | ||||||||||||||
At 30 April 2025 | ||||||||||||||
Depreciation | ||||||||||||||
At 1 May 2024 | ||||||||||||||
At 30 April 2025 | ||||||||||||||
Net book values | ||||||||||||||
At 30 April 2025 | ||||||||||||||
At 30 April 2024 | - | |||||||||||||
6 | Creditors: | |||||||||||||
amounts falling due within one year | ||||||||||||||
2025 | 2024 | |||||||||||||
£ | £ | |||||||||||||
Other creditors | ||||||||||||||
7 | Share Capital | |||||||||||||
100 x £1 Ordinary Shares called up and fully paid | ||||||||||||||
8 | Reserves | |||||||||||||